Need professional-grade analysis? Visit stockanalysis.com
$9.39B
49.73
10,088
0.54%
North China Pharmaceutical Co Ltd (600812) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY5.39, down 1.82% from the previous close.
Over the past year, 600812 has traded between a low of CNY5.18 and a high of CNY7.01. The stock has lost 9.8% over this period. It is currently 23.1% below its 52-week high.
North China Pharmaceutical Co Ltd has a market capitalization of $9.39B, with a price-to-earnings ratio of 49.73 and a dividend yield of 0.54%.
North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical pharmaceuticals; and biological, agricultural, and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China.
Side-by-side comparison against top Healthcare peers.